Andrew Arnold
Impact in
- Nephrology top 0.05%
- Parathyroid Disorders and Treatments
- Oncology top 0.05%
- Cancer-related Molecular Pathways
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
Papers in
- Oncology 105
- Cancer-related Molecular Pathways 32
- Pancreatic and Hepatic Oncology Research 32
- Nephrology 77
- Parathyroid Disorders and Treatments 77
- Co-authors
- Philip W. Hinds (3 shared papers)Robert A. Weinberg (3 shared papers)Randall D. Gaz (11 shared papers)Steven I. Reed (2 shared papers)Toru Motokura (4 shared papers)Lawrence Zukerberg (6 shared papers)Steven F. Dowdy (2 shared papers)Henry M. Kronenberg (8 shared papers)
- Journals
- The Journal of Clinical Endocrinology & Metabolism (25 papers)Journal of Clinical Oncology (25 papers)New England Journal of Medicine (9 papers)Journal of Clinical Investigation (8 papers)Journal of Bone and Mineral Research (7 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Andrew Arnold
234 papers receiving 19.5k citations
Andrew Arnold's Hit Papers
Peers
Comparison fields: 5 of 171
- Nephrology 3.7k
- Oncology 9.7k
- Pathology and Forensic Medicine 2.4k
- Cancer Research 2.0k
- Genetics 1.4k
Countries citing papers authored by Andrew Arnold
This map shows the geographic impact of Andrew Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Arnold more than expected).
Fields of papers citing papers by Andrew Arnold
This network shows the impact of papers produced by Andrew Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Arnold. The network helps show where Andrew Arnold may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Arnold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 240 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A novel cyclin encoded by a bcl1-linked candidate oncogene Hit paper breakdown → | 1991 | 1135 |
| 2 | Regulation of retinoblastoma protein functions by ectopic expression of human cyclins Hit paper breakdown → | 1992 | 943 |
| 3 | Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice Hit paper breakdown → | 1994 | 872 |
| 4 | Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions Hit paper breakdown → | 1995 | 746 |
| 5 | Physical interaction of the retinoblastoma protein with human D cyclins Hit paper breakdown → | 1993 | 693 |
| 6 | Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. Hit paper breakdown → | 1988 | 570 |
| 7 | Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. Hit paper breakdown → | 1993 | 555 |
| 8 | Immunoglobulin-Gene Rearrangements as Unique Clonal Markers in Human Lymphoid Neoplasms Hit paper breakdown → | 1983 | 543 |
| 9 | Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. Hit paper breakdown → | 1983 | 524 |
| 10 | 2003 | 470 | |
| 11 | 1998 | 468 | |
| 12 | 1994 | 422 | |
| 13 | 1988 | 353 | |
| 14 | D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. | 1991 | 342 |
| 15 | 2005 | 337 | |
| 16 | 1995 | 336 | |
| 17 | 1999 | 316 | |
| 18 | 1989 | 309 | |
| 19 | 1990 | 306 | |
| 20 | 1994 | 257 |
About Andrew Arnold
Andrew Arnold is a scholar working on Oncology, Nephrology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 240 papers that have together received 20.6k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (77 papers), Genetic Syndromes and Imprinting (43 papers), Cancer-related Molecular Pathways (32 papers), Pancreatic and Hepatic Oncology Research (32 papers), Neuroendocrine Tumor Research Advances (18 papers), Lymphoma Diagnosis and Treatment (17 papers), Lung Cancer Treatments and Mutations (16 papers) and Chronic Lymphocytic Leukemia Research (15 papers). The work is most often cited by research in Nephrology (3.7k citations), Oncology (9.7k citations), Pathology and Forensic Medicine (2.4k citations), Cancer Research (2.0k citations) and Genetics (1.4k citations). Andrew Arnold has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Philip W. Hinds, Robert A. Weinberg, Randall D. Gaz, Steven I. Reed, Toru Motokura, Lawrence Zukerberg, Steven F. Dowdy, Henry M. Kronenberg, Αλέξανδρος Παπανικολάου and Theodora Bloom. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Clinical Oncology, New England Journal of Medicine, Journal of Clinical Investigation and Journal of Bone and Mineral Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.